Antibody Glycosylation and Inflammation
IgG antibodies are the basis of some of the most effective therapeutics developed over the last 20 years. These antibodies are highly specific, have long serum-half lives, and can be produced relatively routinely, making them ideal drugs for immunotherapy. The degree of regulation on IgG antibody ef...
Main Authors: | Robert M. Anthony, Kai-Ting C. Shade |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-06-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/2/3/392 |
Similar Items
-
Antitumour Activity of a Hinge- and Fc-engineered Chimeric Heavy-chain Antibody
by: D'Eall, Calvin
Published: (2015) -
In Vitro and In Vivo Pharmacology and Pharmacokinetics of a Human Engineered™ Monoclonal Antibody to Epithelial Cell Adhesion Molecule
by: W. Steve Ammons, et al.
Published: (2003-03-01) -
Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
by: Laura E Doepker, et al.
Published: (2021-01-01) -
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
by: Kwok Hang Fai, et al.
Published: (2011-12-01) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
by: Clare Burn Aschner, et al.
Published: (2020-06-01)